SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2AN'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CBR_A_REAA200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE I) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 6 / 12 | PHE A 16PRO A 38THR A 53LEU A 115ARG A 126TYR A 128 | 2AN A 201 ( 4.9A)2AN A 201 ( 4.3A)2AN A 201 ( 4.0A)None2AN A 201 ( 4.9A)None | 0.70A | 1cbrA-3wbgA:19.3 | 1cbrA-3wbgA:39.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CBR_B_REAB200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE I) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 6 / 12 | PHE A 16PRO A 38THR A 53LEU A 115ARG A 126TYR A 128 | 2AN A 201 ( 4.9A)2AN A 201 ( 4.3A)2AN A 201 ( 4.0A)None2AN A 201 ( 4.9A)None | 0.70A | 1cbrB-3wbgA:19.3 | 1cbrB-3wbgA:39.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CBS_A_REAA200_1 (CELLULAR RETINOICACID BINDING PROTEINTYPE II) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 6 / 12 | PHE A 16PRO A 38THR A 53LEU A 115ARG A 126TYR A 128 | 2AN A 201 ( 4.9A)2AN A 201 ( 4.3A)2AN A 201 ( 4.0A)None2AN A 201 ( 4.9A)None | 0.75A | 1cbsA-3wbgA:19.0 | 1cbsA-3wbgA:41.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DZ9_A_CAMA503_0 (CYTOCHROME P450-CAM) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 8 | TYR A 19LEU A 104THR A 53ASP A 76 | 2AN A 201 (-4.8A)None2AN A 201 ( 4.0A)2AN A 201 (-3.9A) | 1.02A | 1dz9A-3wbgA:undetectable | 1dz9A-3wbgA:16.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1KGL_A_RTLA175_0 (CELLULARRETINOL-BINDINGPROTEIN TYPE I) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16ALA A 33PRO A 38SER A 55LEU A 115 | 2AN A 201 ( 4.9A)2AN A 201 (-3.8A)2AN A 201 ( 4.3A)2AN A 201 (-3.2A)None | 0.70A | 1kglA-3wbgA:19.8 | 1kglA-3wbgA:32.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MX8_A_RTLA135_0 (CELLULARRETINOL-BINDINGPROTEIN I, HOLO) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16TYR A 19ALA A 33PRO A 38THR A 40 | 2AN A 201 ( 4.9A)2AN A 201 (-4.8A)2AN A 201 (-3.8A)2AN A 201 ( 4.3A)None | 1.07A | 1mx8A-3wbgA:17.1 | 1mx8A-3wbgA:34.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MX8_A_RTLA135_0 (CELLULARRETINOL-BINDINGPROTEIN I, HOLO) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16TYR A 19ALA A 33PRO A 38THR A 53 | 2AN A 201 ( 4.9A)2AN A 201 (-4.8A)2AN A 201 (-3.8A)2AN A 201 ( 4.3A)2AN A 201 ( 4.0A) | 1.11A | 1mx8A-3wbgA:17.1 | 1mx8A-3wbgA:34.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1O76_B_CAMB1420_0 (CYTOCHROME P450-CAM) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 8 | TYR A 19LEU A 104THR A 53ASP A 76 | 2AN A 201 (-4.8A)None2AN A 201 ( 4.0A)2AN A 201 (-3.9A) | 1.06A | 1o76B-3wbgA:undetectable | 1o76B-3wbgA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1O76_B_CAMB1420_0 (CYTOCHROME P450-CAM) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 8 | TYR A 19LEU A 104THR A 60ASP A 76 | 2AN A 201 (-4.8A)NoneNone2AN A 201 (-3.9A) | 0.89A | 1o76B-3wbgA:undetectable | 1o76B-3wbgA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UYU_A_CAMA1416_0 (CYTOCHROME P450-CAM) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 8 | TYR A 19LEU A 104THR A 53ASP A 76 | 2AN A 201 (-4.8A)None2AN A 201 ( 4.0A)2AN A 201 (-3.9A) | 1.03A | 1uyuA-3wbgA:undetectable | 1uyuA-3wbgA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UYU_B_CAMB1416_0 (CYTOCHROME P450-CAM) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 8 | TYR A 19LEU A 104THR A 53ASP A 76 | 2AN A 201 (-4.8A)None2AN A 201 ( 4.0A)2AN A 201 (-3.9A) | 1.03A | 1uyuB-3wbgA:undetectable | 1uyuB-3wbgA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AOF_C_FRDC305_1 (POL POLYPROTEINPEPTIDE INHIBITOR) |
1txc | PATHOGENESIS-RELATEDCLASS 10 PROTEINSPE-16 (Pachyrhizuserosus) | 4 / 5 | GLY A 139PRO A 36ALA A 57ILE A 55 | 2AN A 716 (-3.7A)2AN A 715 (-4.4A)2AN A 716 (-3.4A)2AN A 716 (-4.2A) | 0.96A | 2aofA-1txcA:undetectable | 2aofA-1txcA:23.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CBR_A_A80A201_1 (PROTEIN (CRABP-I)) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 6 / 12 | PHE A 16VAL A 32THR A 53LEU A 115ARG A 126TYR A 128 | 2AN A 201 ( 4.9A)None2AN A 201 ( 4.0A)None2AN A 201 ( 4.9A)None | 0.87A | 2cbrA-3wbgA:19.3 | 2cbrA-3wbgA:39.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FR3_A_REAA300_1 (CELLULAR RETINOICACID BINDING PROTEIN2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 6 / 12 | PHE A 16PRO A 38THR A 53LEU A 115ARG A 126TYR A 128 | 2AN A 201 ( 4.9A)2AN A 201 ( 4.3A)2AN A 201 ( 4.0A)None2AN A 201 ( 4.9A)None | 0.77A | 2fr3A-3wbgA:19.2 | 2fr3A-3wbgA:41.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2G78_A_REAA200_1 (CELLULAR RETINOICACID-BINDING PROTEIN2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16ALA A 33THR A 40ARG A 106LEU A 115 | 2AN A 201 ( 4.9A)2AN A 201 (-3.8A)NoneNoneNone | 1.07A | 2g78A-3wbgA:19.2 | 2g78A-3wbgA:40.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 10 / 12 | PHE A 16VAL A 25ALA A 33SER A 55THR A 60ALA A 75ASP A 76ARG A 78ARG A 126TYR A 128 | 2AN A 201 ( 4.9A)None2AN A 201 (-3.8A)2AN A 201 (-3.2A)None2AN A 201 ( 3.8A)2AN A 201 (-3.9A)2AN A 201 ( 4.8A)2AN A 201 ( 4.9A)None | 0.66A | 2qm9A-3wbgA:25.0 | 2qm9A-3wbgA:58.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 7 / 12 | VAL A 25ALA A 33SER A 55ALA A 75ASP A 76CYH A 124TYR A 128 | None2AN A 201 (-3.8A)2AN A 201 (-3.2A)2AN A 201 ( 3.8A)2AN A 201 (-3.9A)NoneNone | 1.28A | 2qm9A-3wbgA:25.0 | 2qm9A-3wbgA:58.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | VAL A 25ALA A 33THR A 53ASP A 76ARG A 78 | None2AN A 201 (-3.8A)2AN A 201 ( 4.0A)2AN A 201 (-3.9A)2AN A 201 ( 4.8A) | 1.09A | 2qm9A-3wbgA:25.0 | 2qm9A-3wbgA:58.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | VAL A 25ALA A 33THR A 53ASP A 76CYH A 124 | None2AN A 201 (-3.8A)2AN A 201 ( 4.0A)2AN A 201 (-3.9A)None | 1.04A | 2qm9A-3wbgA:25.0 | 2qm9A-3wbgA:58.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 9 / 12 | PHE A 16TYR A 19VAL A 25SER A 55THR A 60ALA A 75ARG A 78ARG A 126TYR A 128 | 2AN A 201 ( 4.9A)2AN A 201 (-4.8A)None2AN A 201 (-3.2A)None2AN A 201 ( 3.8A)2AN A 201 ( 4.8A)2AN A 201 ( 4.9A)None | 0.62A | 2qm9B-3wbgA:25.5 | 2qm9B-3wbgA:58.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | VAL A 25SER A 55ALA A 75CYH A 124TYR A 128 | None2AN A 201 (-3.2A)2AN A 201 ( 3.8A)NoneNone | 1.21A | 2qm9B-3wbgA:25.5 | 2qm9B-3wbgA:58.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QM9_B_TDZB202_2 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 4 | MET A 20PRO A 38ASP A 76ARG A 106 | 2AN A 201 ( 3.9A)2AN A 201 ( 4.3A)2AN A 201 (-3.9A)None | 0.51A | 2qm9B-3wbgA:25.5 | 2qm9B-3wbgA:58.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2RCT_A_RTLA140_0 (RETINOL-BINDINGPROTEIN II, CELLULAR) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16MET A 20ALA A 33THR A 53LEU A 115 | 2AN A 201 ( 4.9A)2AN A 201 ( 3.9A)2AN A 201 (-3.8A)2AN A 201 ( 4.0A)None | 0.73A | 2rctA-3wbgA:20.2 | 2rctA-3wbgA:38.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZAX_A_CAMA422_0 (CYTOCHROME P450-CAM) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 7 | TYR A 19LEU A 104THR A 53ASP A 76 | 2AN A 201 (-4.8A)None2AN A 201 ( 4.0A)2AN A 201 (-3.9A) | 1.02A | 2zaxA-3wbgA:undetectable | 2zaxA-3wbgA:16.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FWG_B_CAMB420_0 (CAMPHOR5-MONOOXYGENASE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 7 | TYR A 19LEU A 104THR A 53ASP A 76 | 2AN A 201 (-4.8A)None2AN A 201 ( 4.0A)2AN A 201 (-3.9A) | 1.05A | 3fwgB-3wbgA:undetectable | 3fwgB-3wbgA:16.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_Q_TFPQ201_1 (PROTEIN S100-A4) |
2wor | PROTEIN S100-A7 (Homosapiens) | 4 / 8 | GLY A 79ILE A 9MET A 12PHE A 16 | NoneNone2AN A1098 ( 3.8A)None | 0.70A | 3ko0O-2worA:11.33ko0Q-2worA:11.8 | 3ko0O-2worA:25.713ko0Q-2worA:25.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LD6_B_KKKB602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
1txc | PATHOGENESIS-RELATEDCLASS 10 PROTEINSPE-16 (Pachyrhizuserosus) | 5 / 12 | PHE A 119TYR A 82TYR A 80PHE A 142ILE A 55 | NoneNoneNone2AN A 716 ( 4.2A)2AN A 716 (-4.2A) | 1.43A | 3ld6B-1txcA:undetectable | 3ld6B-1txcA:15.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 9 / 12 | PHE A 16MET A 20VAL A 25PRO A 38ASP A 76ARG A 78ARG A 106ARG A 126TYR A 128 | 2AN A 201 ( 4.9A)2AN A 201 ( 3.9A)None2AN A 201 ( 4.3A)2AN A 201 (-3.9A)2AN A 201 ( 4.8A)None2AN A 201 ( 4.9A)None | 0.72A | 3p6gA-3wbgA:24.8 | 3p6gA-3wbgA:59.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6G_A_IZPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 8 / 12 | PHE A 16MET A 20VAL A 25PRO A 38ASP A 76CYH A 124ARG A 126TYR A 128 | 2AN A 201 ( 4.9A)2AN A 201 ( 3.9A)None2AN A 201 ( 4.3A)2AN A 201 (-3.9A)None2AN A 201 ( 4.9A)None | 1.16A | 3p6gA-3wbgA:24.8 | 3p6gA-3wbgA:59.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P6H_A_IBPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 7 | PHE A 16MET A 20ASP A 76ARG A 126TYR A 128 | 2AN A 201 ( 4.9A)2AN A 201 ( 3.9A)2AN A 201 (-3.9A)2AN A 201 ( 4.9A)None | 0.51A | 3p6hA-3wbgA:24.8 | 3p6hA-3wbgA:59.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4A81_A_DXCA1161_0 (MAJOR POLLENALLERGEN BET V 1-A) |
1txc | PATHOGENESIS-RELATEDCLASS 10 PROTEINSPE-16 (Pachyrhizuserosus) | 5 / 12 | ASP A 27LYS A 53ILE A 55VAL A 66TYR A 80 | NoneNone2AN A 716 (-4.2A)2AN A 716 (-4.0A)None | 0.80A | 4a81A-1txcA:21.9 | 4a81A-1txcA:40.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N16_A_CHDA301_0 (CARBONIC ANHYDRASE 2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 8 | GLN A 95PHE A 70THR A 53THR A 60 | NoneNone2AN A 201 ( 4.0A)None | 0.84A | 4n16A-3wbgA:undetectable | 4n16A-3wbgA:18.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QYN_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16MET A 20ALA A 33THR A 53LEU A 115 | 2AN A 201 ( 4.9A)2AN A 201 ( 3.9A)2AN A 201 (-3.8A)2AN A 201 ( 4.0A)None | 0.80A | 4qynA-3wbgA:20.6 | 4qynA-3wbgA:37.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QYN_B_RTLB201_0 (RETINOL-BINDINGPROTEIN 2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16MET A 20THR A 53LEU A 115LEU A 117 | 2AN A 201 ( 4.9A)2AN A 201 ( 3.9A)2AN A 201 ( 4.0A)NoneNone | 0.81A | 4qynB-3wbgA:20.6 | 4qynB-3wbgA:37.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QZT_A_ACTA202_0 (RETINOL-BINDINGPROTEIN 2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 6 | TYR A 19GLU A 72THR A 74GLN A 95 | 2AN A 201 (-4.8A)NoneNoneNone | 0.75A | 4qztA-3wbgA:20.9 | 4qztA-3wbgA:37.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QZU_B_RTLB201_0 (RETINOL-BINDINGPROTEIN 2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16MET A 20ALA A 33THR A 53LEU A 104 | 2AN A 201 ( 4.9A)2AN A 201 ( 3.9A)2AN A 201 (-3.8A)2AN A 201 ( 4.0A)None | 1.33A | 4qzuB-3wbgA:21.1 | 4qzuB-3wbgA:37.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QZU_B_RTLB201_0 (RETINOL-BINDINGPROTEIN 2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16MET A 20ALA A 33THR A 53LEU A 115 | 2AN A 201 ( 4.9A)2AN A 201 ( 3.9A)2AN A 201 (-3.8A)2AN A 201 ( 4.0A)None | 0.72A | 4qzuB-3wbgA:21.1 | 4qzuB-3wbgA:37.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QZU_C_ACTC202_0 (RETINOL-BINDINGPROTEIN 2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 6 | TYR A 19GLU A 72THR A 74GLN A 95LEU A 117 | 2AN A 201 (-4.8A)NoneNoneNoneNone | 0.69A | 4qzuC-3wbgA:21.0 | 4qzuC-3wbgA:37.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QZU_C_RTLC201_0 (RETINOL-BINDINGPROTEIN 2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 6 / 12 | PHE A 16MET A 20ALA A 33THR A 53LEU A 115LEU A 117 | 2AN A 201 ( 4.9A)2AN A 201 ( 3.9A)2AN A 201 (-3.8A)2AN A 201 ( 4.0A)NoneNone | 0.63A | 4qzuC-3wbgA:21.0 | 4qzuC-3wbgA:37.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WNU_B_QDNB602_1 (CYTOCHROME P450 2D6) |
1txc | PATHOGENESIS-RELATEDCLASS 10 PROTEINSPE-16 (Pachyrhizuserosus) | 5 / 9 | LEU A 90PHE A 119ALA A 135ASP A 134ALA A 130 | NoneNone2AN A 716 ( 4.3A)NoneNone | 1.14A | 4wnuB-1txcA:undetectable | 4wnuB-1txcA:16.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5H8T_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16TYR A 19ALA A 33SER A 55LEU A 115 | 2AN A 201 ( 4.9A)2AN A 201 (-4.8A)2AN A 201 (-3.8A)2AN A 201 (-3.2A)None | 0.63A | 5h8tA-3wbgA:20.5 | 5h8tA-3wbgA:35.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 7 / 12 | PHE A 16TYR A 19VAL A 25ALA A 33PRO A 38SER A 55LEU A 115 | 2AN A 201 ( 4.9A)2AN A 201 (-4.8A)None2AN A 201 (-3.8A)2AN A 201 ( 4.3A)2AN A 201 (-3.2A)None | 0.81A | 5hbsA-3wbgA:20.3 | 5hbsA-3wbgA:35.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJB_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 6 / 12 | PHE A 16TYR A 19ALA A 33PRO A 38SER A 55LEU A 115 | 2AN A 201 ( 4.9A)2AN A 201 (-4.8A)2AN A 201 (-3.8A)2AN A 201 ( 4.3A)2AN A 201 (-3.2A)None | 0.93A | 5ljbA-3wbgA:20.3 | 5ljbA-3wbgA:32.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJC_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16TYR A 19ALA A 33SER A 55LEU A 115 | 2AN A 201 ( 4.9A)2AN A 201 (-4.8A)2AN A 201 (-3.8A)2AN A 201 (-3.2A)None | 0.75A | 5ljcA-3wbgA:20.5 | 5ljcA-3wbgA:33.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJC_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | TYR A 19ALA A 33PRO A 38SER A 55LEU A 115 | 2AN A 201 (-4.8A)2AN A 201 (-3.8A)2AN A 201 ( 4.3A)2AN A 201 (-3.2A)None | 0.83A | 5ljcA-3wbgA:20.5 | 5ljcA-3wbgA:33.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LJE_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 5 / 12 | PHE A 16ALA A 33PRO A 38SER A 55LEU A 115 | 2AN A 201 ( 4.9A)2AN A 201 (-3.8A)2AN A 201 ( 4.3A)2AN A 201 (-3.2A)None | 0.77A | 5ljeA-3wbgA:20.7 | 5ljeA-3wbgA:33.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M78_A_SALA304_1 (CARBONIC ANHYDRASE 2) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 7 | GLN A 95PHE A 70THR A 53THR A 60 | NoneNone2AN A 201 ( 4.0A)None | 0.95A | 5m78A-3wbgA:undetectable | 5m78A-3wbgA:19.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CP4_A_CAMA422_0 (CYTOCHROME P450CAM) |
3wbg | FATTY ACID-BINDINGPROTEIN, HEART (Homosapiens) | 4 / 8 | TYR A 19LEU A 104THR A 53ASP A 76 | 2AN A 201 (-4.8A)None2AN A 201 ( 4.0A)2AN A 201 (-3.9A) | 1.00A | 6cp4A-3wbgA:undetectable | 6cp4A-3wbgA:16.63 |